| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 13.882 | 37.057 | 66.080 | 126.305 |
| Total Income - EUR | - | - | - | - | - | - | 13.882 | 37.060 | 66.689 | 126.373 |
| Total Expenses - EUR | - | - | - | - | - | - | 12.752 | 37.158 | 60.427 | 126.300 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 1.130 | -98 | 6.262 | 72 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 994 | -413 | 5.633 | 72 |
| Employees | - | - | - | - | - | - | 1 | 1 | 2 | 4 |
Check the financial reports for the company - P.s. Moderna S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 83 |
| Current Assets | - | - | - | - | - | - | 15.199 | 14.755 | 24.883 | 34.094 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 2.715 | 95 | 160 | 319 |
| Cash | - | - | - | - | - | - | 12.483 | 14.660 | 24.723 | 33.775 |
| Shareholders Funds | - | - | - | - | - | - | 1.034 | 624 | 6.244 | 170 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 14.165 | 14.131 | 18.639 | 34.007 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7820 - 7820" | |||||||||
| CAEN Financial Year |
7820
|
|||||||||
Comments - P.s. Moderna S.r.l.